Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Edesa Biotech, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −4 vs. Q1 2023
- Shares held
- 2.01M
- −239.2K (−10.6%) vs. Q1 2023
- Total value
- $1.63M
- −$423.2K (−20.6%) vs. Q1 2023
- New holders
- 1
- 3 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 1,281,615 | $1.04M | 0.98% | 00.0% | Unchanged |
| CM Management, LLC | 375,000 | $304.0K | 0.30% | +50,000+15.4% | Added |
| Vanguard Group Inc | 110,882 | $89.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 86,696 | $69.4K | 0.00% | 00.0% | Unchanged |
| CIBC World Markets Inc. | 54,626 | $44.0K | 0.00% | +54,626 | New |
| State Street Corp | 43,975 | $35.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 22,540 | $18.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 11,571 | $9.38K | 0.00% | −15,137−56.7% | Reduced |
| Dimensional Fund Advisors LP | 11,053 | $8.84K | 0.00% | −6,734−37.9% | Reduced |
| Tower Research Capital LLC (TRC) | 8,521 | $6.91K | 0.00% | −1,120−11.6% | Reduced |
| Royal Bank of Canada | 1,375 | $1.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1,000 | $800 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 700 | $568 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 518 | $420 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 175 | $142 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 135 | $109 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 117 | $95 | 0.00% | +7+6.4% | Added |
| National Bank of Canada | 56 | $45 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 33 | $27 | 0.00% | −5,669−99.4% | Reduced |
| AllSquare Wealth Management LLC | 10 | $9 | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 9 | $7 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8 | $6 | 0.00% | +4+100.0% | Added |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −287,500−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,502−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |